Olodaterol

112 interactions 5 explained in plain English
Also sold as: Striverdi
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Olodaterol Glasdegib Daurismo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Goserelin Implant Zoladex An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Granisetron Injection Granisol An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Histrelin Implant Supprelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Hydroxychloroquine Plaquenil An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Inotuzumab Ozogamicin Injection Besponsa An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Ivabradine Corlanor An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Ketoconazole Topical Extina® Foam An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Labetalol Normodyne® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Lefamulin Xenleta An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Lenvatinib Lenvima An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Levobunolol Ophthalmic AKBeta® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Levofloxacin Levaquin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Levofloxacin Injection Levaquin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Linezolid Injection Zyvox Potentiated cardiovascular effects Details Olodaterol Loperamide Diamode An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Mefloquine Lariam® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Methylphenidate Adhansia XR® An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Methylphenidate Transdermal Patch Daytrana An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Metronidazole Flagyl An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Metronidazole Injection Flagyl An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Metronidazole Topical MetroCream® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Moxifloxacin Avelox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Moxifloxacin Injection Avelox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Nadolol Corgard Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Nafarelin Nasal Spray Synarel An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Nebivolol Bystolic Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Octreotide Bynfezia An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Octreotide Injection Bynfezia An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Ofloxacin Floxin® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oxaliplatin Injection Eloxatin® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Penbutolol Levatol® Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.